What Is Alcohol Intolerance?

.png?sfvrsn=bc50df3d_5)
Signs and Symptoms of Alcohol Intolerance
- Flushing and redness on the face, neck, and chest
- Stuffy or runny nose
- Nausea and vomiting
- Low blood pressure (hypotension)
- Diarrhea
- Heart palpitations or rapid heartbeat (tachycardia)
- Throbbing headache
- Worsening asthma
Causes and Risk Factors of Alcohol Intolerance
Some people are more likely to have an alcohol intolerance than others. They include:
- People of East Asian Descent Researchers estimate about 36 to 45 percent of people from East Asian countries, including Japan, China, Korea, and Taiwan, have an alcohol intolerance. Some researchers refer to this phenomenon as “Asian flush.”
- People With Chronic Fatigue Syndrome Some researchers suggest that those diagnosed with myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS) may be more likely to experience alcohol intolerance than the general population. It’s important to note, though, that studies on the link between ME/CFS and alcohol intolerance have had mixed findings, and more research is needed to explore the link between the two.
- People With Long COVID Anecdotal reports of people with post-acute COVID-19 syndrome (PACS), also known as long COVID, having new or heightened alcohol sensitivities prompted researchers to study the link between long COVID and alcohol intolerance. While it’s still unclear why some with long COVID experience a lower tolerance for alcohol, limited research suggests it could be due to changes in prostaglandin levels (substances in the body that affect functions like inflammation) or the gut microbiome (gut bacteria) post-COVID.
- People With Hodgkin Lymphoma Alcohol intolerance is a potential symptom of Hodgkin lymphoma, a type of cancer.
How Is Alcohol Intolerance Diagnosed?
Treatment and Medication Options for Alcohol Intolerance
Prevention of Alcohol Intolerance
Alcohol Intolerance Prognosis
Complications of Alcohol Intolerance
- Increased risk of cancer: Researchers say people with the ALDH2 gene who keep drinking are at a higher risk of developing cancer — specifically esophageal cancer, liver cancer, and oral cancers. Scientists urge people with the hallmark symptom of flushing to pay attention to this symptom because it’s an indicator of increased genetic risk for cancer.
- Increased risk of heart disease: Researchers have also linked the ALDH2 gene to coronary artery disease, suggesting the enzyme deficiency tied to this gene mutation causes damage in the cells that line the inside of blood vessels.
Research and Statistics: How Many People Have Alcohol Intolerance?
Related Conditions: Alcohol Allergy
If you’re not sure if you have alcohol intolerance or an alcohol allergy, talk to your doctor. They can help you figure out if you have either of these conditions or refer you to an allergist for testing.
The Takeaway
- Alcohol intolerance is a genetic condition that inhibits the body’s ability to metabolize alcohol, causing immediate symptoms like skin redness or flushing and a stuffy nose.
- Alcohol intolerance is most common in people of East Asian descent, though it can impact anyone.
- There’s a difference between a true genetic intolerance of alcohol (caused by the ALDH2 genetic mutation) and someone who may be allergic to one or more ingredients in alcohol.
- The only way to prevent the symptoms of alcohol intolerance is to avoid drinking alcohol. Doing so may prevent complications such as cancer and heart disease.
Common Questions & Answers
Resources We Trust
- Cleveland Clinic: Alcohol Intolerance
- Mayo Clinic: Alcohol Intolerance
- National Institute on Alcohol Abuse and Alcoholism: Alcohol’s Effect on Health
- Cedars-Sinai: Alcohol Intolerance: What You Need to Know
- SUN Behavioral: Alcohol Intolerance: What Is It and Is It Serious?
- Alcohol Intolerance: Symptoms and Causes. Mayo Clinic. April 6, 2023.
- Alcohol Intolerance. Cleveland Clinic. August 24, 2020.
- Jeon S et al. The alcohol flushing response is associated with the risk of depression. Scientific Reports. July 22, 2022.
- Moh I et al. The Alcohol Flush Response. Graphic Medicine Review. February 22, 2024.
- Maciuch J et al. Alcohol intolerance and myalgic encephalomyelitis/chronic fatigue syndrome. World Journal of Neurology. May 31, 2023.
- Eastin EF et al. New Alcohol Sensitivity in Patients With Post-acute Sequelae of SARS-CoV-2 (PASC): A Case Series. Cureus. December 29, 2023.
- Hoppe RT et al. Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. June 2020.
- Chen C et al. ALDH2 variance in disease and populations. Disease Models & Mechanisms. June 24, 2022.
- Alcohol Flush Signals Increased Cancer Risk among East Asians. National Institutes of Health.
- Ng CS et al. ALDH2 polymorphism, alcohol intake and the attributable burden of cancer in East Asia: systematic review, meta-analysis, and modeling study. Annals of Epidemiology. September 2023.
- Guo H et al. SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common ALDH2 alcohol flushing variant. Science Translational Medicine. January 25, 2023.
- Yook HJ et al. Epidemiologic relationship between alcohol flushing and smoking in the Korean population: the Korea National Health and Nutrition Examination Survey. Scientific Reports. July 8, 2024.
- Alcohol Intolerance: What You Need to Know. Cedars-Sinai. November 3, 2023.

Joy Tanaka, PhD
Medical Reviewer
Joy Tanaka, PhD, specializes in clinical molecular genetics. She is dedicated to integrating excellent clinical care with cutting-edge medical research for patients with rare and undiagnosed disorders, and is focused on pursuing questions at the interface between genetics and human disease with the goal of developing novel therapies and treatments.
Dr. Tanaka received her PhD from Yale University School of Medicine, where she was a Howard Hughes Medical Institute Medical Research Scholar and recipient of the George Robert Pfeiffer Fellowship for Translational Medicine. She completed her clinical fellowship in cytogenetics and clinical molecular genetics at Columbia University and New York Presbyterian Hospital, and is currently associate clinical laboratory director at Rady Children's Hospital Institute for Genomic Medicine in San Diego, California.

Carmen Chai
Author
Carmen Chai is a Canadian journalist and award-winning health reporter. Her interests include emerging medical research, exercise, nutrition, mental health, and maternal and pediatric health. She has covered global healthcare issues, including outbreaks of the Ebola and Zika viruses, anti-vaccination movements, and chronic diseases like obesity and Alzheimer’s.
Chai was a national health reporter at Global News in Toronto for 5 years, where she won multiple awards, including the Canadian Medical Association award for health reporting. Her work has also appeared in the Toronto Star, Vancouver Province, and the National Post. She received a bachelor’s degree in journalism from Ryerson University in Toronto.